Data / Form D filings / Auxergen Biolongevity Laboratory
Auxergen Biolongevity Laboratory: Form D filing
Auxergen Biolongevity Laboratory, a company in Baltimore, MD, filed a Form D with the SEC in 2023. The latest, on May 24, 2023, reports $25,000 sold of a $5 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 701 EAST PRATT STREET SUITE 4011, Baltimore, MD, 21202
- Phone
- (410) 336-9877
- Industry
- Other
- Entity type
- Limited Liability Company
- Incorporated in
- Maryland
- Year incorporated
- 2022
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1969864
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 24, 2023 | New notice | $5,000,000 | $25,000 | $4,975,000 | 2 | Apr 24, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gregory Paul Contreras | Executive Officer, Director | |
| Ting Yu Yeh | Executive Officer, Director |
Other companies in Maryland that filed recently
- Hirostar USA, Inc. $1.2 million · Oct 27, 2026
- Hop Flyt, Inc. $1.5 million · Oct 14, 2026
- C&R Auto Inc. offering · Oct 13, 2026
- JBS Touring LLC $2.9 million · Sep 22, 2026
- Throne Labs, Inc. $14.1 million · Sep 17, 2026
- LeanOnWe Care, Inc. $500,010 · Sep 10, 2026
Every Form D from the week of May 22, 2023 · All recent filings in Maryland · All recent Other filings
Read from SEC EDGAR. Amount sold is what Auxergen Biolongevity Laboratory reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.